Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
Healthcare inflation outpaces CPI due to provider shortages. Find out why income investing ensures steady returns despite ...
The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...
To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing ...
The Hain Celestial Group, Inc. ( NASDAQ: HAIN) Q2 2025 Earnings Conference Call February 10, 2025 8:00 AM ET Alexis Tessier - VP, IR Wendy Davidson - President & CEO Lee Boyce - CFO ...
Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type ...
In contrast, survivors who breathed in polluted air from the Camp fire -- a 2018 blaze that remains the deadliest and most destructive wildfire in California's history -- showed no increased risk ...
Mounjaro and Zepbound are part of a wave of diabetes and obesity medications known as GLP-1 receptor agonists that are soaring in popularity globally due to the amount of weight people lose while ...